Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

IRONBearishMarket Recapnews

High materiality7/10

Progress Software, Disc Medicine And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Jan 22, 2025, 8:34 AM EST1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

Disc Medicine's stock decline suggests negative market sentiment affecting investor confidence. Similar offerings often lead to short-term price decreases.

AI summary

What happened, with direct paths to the underlying reporting

U.S. stock futures increased, particularly Nasdaq futures gained over 150 points. Progress Software's shares fell after providing disappointing first-quarter EPS guidance. Disc Medicine, Inc. IRON fell 2.7% following a proposed $200 million public offering.

U.S. stock futures increased, particularly Nasdaq futures gained over 150 points.
Progress Software's shares fell after providing disappointing first-quarter EPS guidance.
Disc Medicine, Inc. IRON fell 2.7% following a proposed $200 million public offering.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.

Progress Software, Disc Medicine And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Disc Medicine to pursue traditional U.S. approval after FDA rejects new fast-track route

US FDA declines to approve Disc Medicine's rare disease drug

Disc Medicine Analyst Remains Confident In Rare Disease Drug Despite FDA Action